ENTA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ENTAEnanta Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ENTAEnanta Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ENTA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.1%▼−2.10%×0.11

Q2 FY26±19.0%▼−6.02%×0.32

Q1 FY26±13.1%▲+2.17%×0.17

Nov 18 '25±17.1%▼−3.59%×0.21

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedENTA realized, solidLLY realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ENTAEnanta Pharmaceuticals Inc

10.86▲+7.69%· post 10.86

Mkt cap$320.4MRevenue$14MQ3 FY26Revenue$67MFY24

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

ENTAEnanta Pharmaceuticals Inc

LLYELI Lilly & Co

10.86▲+7.69%post 10.86

Price

1,360.90▼−0.28%post 1,358.90

$320.4M

Mkt cap

$1.2T

Q3 FY26$14M

Revenue

$24.4BQ3 FY26

FY24$67M

Revenue

$65.2BFY25

ENTA10.86▲+7.69%vsLLY1,360.90▼−0.28%ClosedNov 6 '26